BUY Fortis Healthcare — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)7 Nov 2026via Moneycontrol Broker Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
12 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·9 Nov · 5d ago
Fortis Healthcare shares in focus after revenue, EBITDA rise in Q2 - A look at how its business segments fared
NewsCnbc-Tv18·6 Nov · 1w ago
Fortis Healthcare reported Q2 FY27 consolidated revenue of INR 2,735 Cr, up 17.3% YoY. The company also announced the acquisition of Suguna Hospital in Bengaluru and a new hospital project in Delhi.
BSE · Company Update·5 Nov · 1w ago
Fortis Healthcare acquires Bengaluru’s Suguna Hospital for ₹277 crore
NewsCnbc-Tv18·28 Oct · 2w ago
Fortis Healthcare acquired Suguna Hospital in Bengaluru for approximately INR 277 crores, with potential to scale to 150 beds.
NSE · Press Release·28 Oct · 2w ago
Nothing found in this tip’s window yet.
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·13 Nov · yesterday
Fortis Healthcare Q2 profit falls 3% as lower exceptional gain offsets revenue growth
NewsCnbc-Tv18·5 Nov · 1w ago
HCG, Apollo Hospitals, Max, Fortis Health share price could see further pressure today; Here's why
NewsCnbc-Tv18·19 Oct · 4w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Fortis Healthcare
- BUY — Axis Securities9 Nov 2026 · ~1 year · target ₹845 · Active
- BUY — Kunal Bothra4 Nov 2026 · ~2 weeks · target ₹900 · Active
- BUY — Prakash Gaba2 Nov 2026 · Same day · target ₹790 · SL hit
- BUY — Ansh Jogendra Bhilwar29 Oct 2026 · Same day · target ₹792 · Expired
- SELL — Manas Jaiswal14 Oct 2026 · ~2 weeks · target ₹660 · Expired
More from Motilal Oswal
- BUY Gland Pharma12 Nov 2026 · ~1 year · target ₹3,690 · Active
- BUY GNG Electronics12 Nov 2026 · ~1 year · target ₹840 · Active
- BUY Triveni Turbine12 Nov 2026 · ~1 year · target ₹610 · Active
- BUY TURTLEMINT FINTECH SOLUTIONS12 Nov 2026 · ~1 year · target ₹75 · Active
- BUY Coromandel International12 Nov 2026 · ~1 year · target ₹2,400 · Active

